Startup CrowdMed uses a mix of prediction market software, crowdsourcing, and gamification to help patients gain insight from hundreds of medical detectives. Watching his sister visit doctor after doctor, in fruitless pursuit of a diagnosis and treatment…
Category Archives: Pharmaceuticals and Medical Products
Strategy Scenarios: Business Turnaround
Strategy Consulting: Strategy scenarios allow organizations to easily respond to changes and transition between necessary actions during the business turnaround execution
Case Study: Maintenance Cost Reduction with RCP
Dramatic and sustainable pharmaceutical plant maintenance annual cost reductions with WGA’s Recommended Current Practices RCP Benchmark service.
Case Study: Pharmaceutical Maintenance Excellence with RCP
Unnecessary supply disruptions caused by maintenance and spare part management failures resolved with Pharmaceutical Maintenance Excellence with WGA’s RCP
Case Study: Pharmaceutical Maintenance – WGA’s RCP benchmark
FDA regulatory maintenance findings threatens $2.3 Billion/year in pharmaceutical trade revenue. WGA’s RCP Pharmaceutical Maintenance benchmark case study
Case Study: Business Project Governance
Instant growth often results in a deluge of concurrent business projects. For most of us in operations, been there, done that. However, if your organization is lacking robust business project governance, precious capital could be wasted, resources tied up and far worse, the business value of those business projects may not be achieved to enable or sustain the current growth.
Case Study: Skin Care FDA Regulatory Changes
DA regulatory change requires fast response for a $3 Billion+/year skin care business.
The FDA issued regulatory changes to the skin care industry in June of 2011 regarding the terms, “sunblock”, “waterproof” and “sweatproof” requiring the removal of such claims from product labeling and packaging. These changes were initially required to be completed by June of 2012
Sustaining Unified Business Process Adoption
WGA successfully completes Global Unified Business Process consolidation project for Global Pharmaceutical Industry Client reduces annual costs by $427M.
Case Study: Is Sustainable Change an oxymoron?
Is Sustainable Change an oxymoron? Would it be change if it was ‘sustained’ and didn’t change? Obviously change is a disciple. Change is a culture.
Case Study: Learning to Fail, Innovation and a Culture of Learning
For many companies, reaching a high level of innovation and success does not come immediately. Many of them need a “come from behind” strategy in order to be market leaders. Others need to hit the depths of failure before they can rise up Phoenix-like and reach new heights of success.